Case Report
SARS-CoV-2 Infection as a Determining Factor to the Precipitation of Ischemic Priapism in a Young Patient with Asymptomatic COVID-19
Table 1
Key laboratory tests at admission. MCV: mean cellular volume; ESR: erythrocyte sedimentation rate; CRP: C-reactive protein; n/a: not applicable.
| | Patient | Laboratory standard |
| | Erythrocytes (×106/μL) | 3.07 | 4.54-5.78 | | Leukocytes (×103/μL) | 8.61 | 3.7-9.7 | | Hemoglobin (g/dL) | 9.3 | 13.3-17.2 | | Hematocrit (%) | 26.9 | 38.9-50.9 | | MCV (fl) | 87.4 | 81.2-94 | | Neutrophils (%) | 68.9 | 42.9-78.4 | | Eosinophiles (%) | 4 | 0.3-6.2 | | Basophiles (%) | 0.5 | 0.3-1.3 | | Lymphocytes (%) | 20.9 | 14.1-45.8 | | Monocytes (%) | 5.7 | 3.3-9.2 | | Platelets (×103/μL) | 363 | 179-373 | | Urea (mg/dL) | 28 | 15-38 | | Bilirubin (mg/dL) | 0.32 | 0.2-1 | | Glucose (mg/dL) | 95 | <100 | | Glycated hemoglobin (mmol/mol) | 36 | 20-42 | | Prothrombin time (INR) | 1.01 | n/a | | Fibrinogen (mg/dL) | 429 | 200-400 | | Activated partial thromboplastin time (ratio) | 0.89 | <1.20 | | D-dimers (μg/L) | 5855 | <500 | | Homocysteine (mmol/L) | 21.7 | 3.2-10.7 | | Antithrombin III (%) | 116 | 80-130 | | ESR (mm/h) | 69 | 1-15 | | CRP (mg/L) | 37.5 | <2.9 | | Presepsin (pg/mL) | 351 | 20-200 | | IL-6 (μg/L) | 76.4 | 0-7 | | Procalcitonin (ng/mL) | 1.19 | 0-0.05 |
|
|
